Global Topical Antibiotics Market – Industry Trends and Forecast to 2029

Topical Antibiotics Market Analysis and Size

The global topical antibiotics market is expected to witness significant growth during the forecast period. Topical antibiotics are applied to a specific area of the skin in order to kill infections. Among several indications such as the skin, eye, and Bromhidrosis, the use of topical antibiotics to fight bacterial skin infection has witnessed steady growth over the past few years. A large variety of bacteria such as Staphylococcus aureus, Streptococcus viridians, and Streptococcus pyogenes are responsible for these infections. Numerous antibiotics need high concentrations for gaining ability to completely remove bacteria from skin surface. Systemic absorption of mupirocin and retapamulin through skin is very less in cases of undamaged skin.

Data Bridge Market Research analyses a growth rate in the global topical antibiotics market in the forecast period 2022-2029. The expected CAGR of global topical antibiotics market is tend to be around 6.3% in the mentioned forecast period. The market was valued at USD 6.55 billion in 2021, and it would grow upto USD 10.68 billion by 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Topical Antibiotics Market Scope and Segmentation

Market Definition

Topical antibiotics are the class of antibiotics that hinder bacterial cell wall growth. A range of topical antibiotics can be prescribed as OTC or prescription and are extensively used in the treatment of eye infectious diseases. Application of topical antibiotics has several benefits compared to systemic delivery in treating skin infections. Most of these infections are minor and chronic in nature that causes irritation and can be treated as outpatient procedures. It is of great importance to the healthcare sector and thus is expected to rise high in the forecast period

Global Topical Antibiotics Market Dynamics

Drivers

• Increase in Surgical Site Infection

Surgical site infection (SSI) is one of the most common complications and a top cause of hospital acquired infections globally. The occurrence and incidence rates are higher in low and middle-income countries. Surgical site infection in spine surgery is one of the most common complications post surgery. Above 40,000 patients in the U.S. witnessed surgical site infection after spine surgery. This boost the market growth.

• Higher Agreements and Partnerships

Ongoing product approvals and strategic initiatives undertaken by major market players such as, partnerships, product launches, collaborations, expansions are anticipated to boost the market growth during the forecast period. For instance, in September 2021 AuroMedics Pharma LLC announced that it has got an approval from USFDA to manufacture Daptomycin for an injection. Furthermore, in July 2022, Boehringer Ingelheim, Evotec SE, and bioMérieux announced that they have created a joint venture to make the next generation of antimicrobials to fight against antimicrobial resistance. Thus, it boosts the market growth.

Opportunities

• Growing Antimicrobial Resistance

The increasing incidence of antimicrobial resistance is also estimated to boost the topical antibiotics market. For instance, as per the reports of CDC on Antibiotics Resistance Threats in US 2019 report, 2.8 million antimicrobial resistance cases are recorded in the U.S. each year with around 35,000 deaths every year. Furthermore, CDC is implementing funding activities through CDC’s Antimicrobial Resistance Initiative that support more than 50 state health departments, and several local health departments. CDC has also combined with state and local health departments, federal agencies, and the private sector to mitigate antimicrobial resistance. This creates more opportunity for the market growth.

• Rising Healthcare Awareness

Patients with improper hygiene, a weak immune system, an infected epidermis, and close contact with people with epidermal disease are vulnerable to illness. Thus, the increasing awareness of topical antibiotic pharmaceuticals is anticipated to boost the market demand. Technological advancements are considered to play a critical role in the rising demand for the product. Antibiotic pharmaceuticals are among the most frequently used product by the consumers. Topical antibiotic pharmaceuticals are extensively used in several indications, from infections in cuts and mild to extreme acne cases. An extensive increase in awareness of these OTC products is creating more opportunity in the market.

Restraints/Challenges

• Lack of Skilled Professionals

Lack of trained professionals who are unaware of the knowledge of the treatment methods for this disease could curb the growth of the global topical antibiotics market over a forecast period.

• Increasing Cost Of Treatments

The huge expenditure required for the treatment methods surely hamper the market growth. Many of the treatments involved in this disease require high cost and thus at times, gets difficult for many people, especially the ones in the rural areas. Thus, this can act as a major hindrance factor for the market.

This global topical antibiotics market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global topical antibiotics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Global Topical Antibiotics Market

Skin infections continue to affect millions of individuals globally, but the global healthcare sector is mainly focusing and engaged in restricting the transmission of the novel coronavirus infection. In addition to this, R&D activities are also focusing at the development of a vaccine. Though, the production and development of topical antibiotics are most likely to remain unaffected worldwide, as drug manufacturers and the pharmaceutical sector are released from lockdown measures enforced by governments worldwide.

The growth is slower comparatively in the post pandemic era but is expected to rise high in the coming years.

Global Topical Antibiotics Market Scope

The global topical antibiotics market is segmented on the basis of application, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Application

• Non-Hodgkin Lymphoma
• Hodgkin Lymphoma
• Acute Myelogenous Leukemia
• Chronic Lymphocytic Leukemia
• Solid Tumor
• Epithelial Tumor
• Others

Route of Administration

• Parenteral
• Others

End-Users

• Hospitals
• Homecare
• Speciality Centres
• Others

Distribution Channel

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

Topical Antibiotics Market Regional Analysis/Insights

The global topical antibiotics market analysed and market size insights and trends are provided by application, route of administration, distribution channel and end-user as referenced above.

The major countries covered in the global topical antibiotics market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Asia-Pacific is expected to have the highest market growth due to the key generic players and increases focuses on the research and development activity.

North America dominates the market due to the high prevalence of bacterial eye infections, sophisticated medical facilities and rise in government initiatives..

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Topical Antibiotics Market Share Analysis

The global topical antibiotics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global topical antibiotics market.

Key players operating in the global topical antibiotics market include:

• F. Hoffmann-La Roche Ltd. (Switzerland)
• Mylan N.V. (U.S.)
• Sanofi (France)
• Pfizer Inc. (U.S.)
• GSK plc (U.K.)
• Novartis AG (Switzerland)
• Bayer AG (Germany)
• Lilly (U.S.)
• Merck & Co., Inc. (U.S.)
• Sun Pharmaceutical Industries Ltd. (India)
• Aurobindo Pharma (India)
• Lupin (India)
• Fresenius Kabi AG (Germany)
• Akorn Incorporated (U.S.)
• Teva Pharmaceutical Industries Ltd (Israel)

SKU-54465